COLA requests expansion of GAO report on PAMA to Include Patient Impact

COLA, a nationally recognized private, non-profit laboratory accreditation organization, recently sent a letter to the U.S. Government Accountability Office (GAO) requesting an expansion of its recent report on the implementation of rate cuts to the Clinical Laboratory Fee Schedule (CLFS). The GAO, in a November 2018 report entitled, “Medicare Laboratory Tests: Implementation of New Rates…

COLA comments on new Clinical Laboratory Fee Schedule

COLA Shares Data on the Impact of Medicare Cuts on Patient Access to Clinical Laboratory Testing

COLA, a physician-directed, non-profit laboratory accrediting organization, recently pointed to their study data showing the importance of near patient testing to the elderly and medically frail and calls upon the Centers for Medicare and Medicaid Services (CMS) and Congress to consider how the anticipated steep cuts from the new Clinical Laboratory Fee Schedule will harm access…